Burrows Scott L 4
4 · Arcutis Biotherapeutics, Inc. · Filed Sep 20, 2022
Insider Transaction Report
Form 4
Burrows Scott L
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-09-16$1.68/sh+5,000$8,403→ 40,256 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-09-16−5,000→ 37,277 totalExercise: $1.68Exp: 2029-06-11→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]Includes 17,400 restricted stock units.
- [F2]25% of the shares subject to the option vest on the one year anniversary measured from May 22, 2019 (the "Vesting Commencement Date") and 1/48th of the shares vest on each monthly anniversary thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.